Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Allergy, Asthma & Clinical Immunology
Published in: Allergy, Asthma & Clinical Immunology 2/2014

Open Access 01-12-2014 | Meeting abstract

The early life gut microbiota and atopic disease

Authors: Leah T Stiemsma, Marie-Claire Arrieta, Pedro A Dimitriu, Lisa Thorson, Sophie Yurist, Rollin Brandt, Diana L Lefebvre, Padmaja Subbarao, Piush Mandhane, Allan Becker, Malcolm Sears, Tobias Kollmann, William W Mohn, B Brett Finlay, Stuart E Turvey, the CHILD Study Investigators

Published in: Allergy, Asthma & Clinical Immunology | Special Issue 2/2014

Login to get access

Excerpt

Asthma is the most prevalent of all childhood diseases and accounts for the majority of hospitalizations and school absences in children [1]. Current mouse model research has identified the early life gut microbiota as a potential therapeutic target for the prevention of asthma and atopic diseases [2‐4]. We hypothesize that the early life gut microbiota could play a similar preventative role against atopic disease development in humans. …
Literature
1.
2.
Zeng B, Li G, Yuan J, Li W, Tang H, Wei H: Effects of age and strain on the microbiota colonization in an infant human flora-associated mouse model. Current Microbiology. 2013, 67: 313-21.CrossRefPubMed
3.
Russell SL, Gold MJ, Willing BP, Thorson L, McNagny KM, Finlay BB: Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes. 2013, 4: 158-64. 10.4161/gmic.23567.PubMedCentralCrossRefPubMed
4.
Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C, Muller A: Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. The Journal of Clinical Investigation. 2011, 121: 3088-3093. 10.1172/JCI45041.PubMedCentralCrossRefPubMed
Metadata
Title
The early life gut microbiota and atopic disease
Authors
Leah T Stiemsma
Marie-Claire Arrieta
Pedro A Dimitriu
Lisa Thorson
Sophie Yurist
Rollin Brandt
Diana L Lefebvre
Padmaja Subbarao
Piush Mandhane
Allan Becker
Malcolm Sears
Tobias Kollmann
William W Mohn
B Brett Finlay
Stuart E Turvey
the CHILD Study Investigators
Publication date
01-12-2014
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1710-1492-10-S2-A63

Other articles of this Special Issue 2/2014

Allergy, Asthma & Clinical Immunology 2/2014 Go to the issue

Meeting abstract

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada

Meeting abstract

Tiotropium respimat® add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of TH2 inflammatory status

Meeting abstract

Retracted Article: A post-hoc qualitative analysis of real time heads-up pollen counting versus traditional microscopy counting in the environmental exposure unit (EEU)

Meeting abstract

Anaphylaxis associated with folic acid: domestic case review

Meeting abstract

Tobacco smoke induces changes in IL-1 family in bronchial epithelial cells obtained from asthmatic individuals

Meeting abstract

Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population